Drugs / cylcophosphamide
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00725231 Background | Feb 2008 → Mar 2014 | angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified | University of Göttingen | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cylcophosphamide | “chemotherapy cylcophosphamide, hydroxyldaunorubicin” NCT00725231 ↗ |